To achieve capital growth.
Name | % Net Assets |
---|---|
ALEXION PHARMACEUTICALS | 4.2% |
HMS HOLDINGS | 4.0% |
ROCHE HOLDING BON JOUISSANCE | 3.7% |
FRESENIUS MEDICAL CARE AG & CO.KGAA | 3.5% |
EXPRESS SCRIPTS INC | 2.8% |
DAVITA INC | 2.7% |
MERCK & CO INC | 2.6% |
ABBOTT LABORATORIES | 2.5% |
UNITEDHEALTH GROUP INC | 2.5% |
PFIZER INC | 2.5% |
Key | % Net Assets |
---|---|
ALEXION PHARMACEUTICALS | 4.2% |
HMS HOLDINGS | 4.0% |
ROCHE HOLDING BON JOUISSANCE | 3.7% |
FRESENIUS MEDICAL CARE AG & CO.KGAA | 3.5% |
Other | 84.6% |
Date | 21-Nov-2024 |
---|---|
NAV | 3,113.00p |
Currency | GBP |
Change | 41.00p |
% | 1.33% |
YTD change | 75.00p |
YTD % | 2.47% |
Fund Inception | 27/02/1987 |
---|---|
Fund Manager | DEANE DONNIGAN |
TER | 1.58 (31-Oct-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 5.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.17 |
You are here: research